RWA Wealth Partners LLC Has $7.53 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

RWA Wealth Partners LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1,354.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 22,327 shares of the medical equipment provider’s stock after purchasing an additional 20,792 shares during the period. RWA Wealth Partners LLC’s holdings in Intuitive Surgical were worth $7,532,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Baystate Wealth Management LLC lifted its position in Intuitive Surgical by 150.0% during the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 45 shares during the last quarter. MCF Advisors LLC lifted its position in Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 40 shares during the last quarter. Atticus Wealth Management LLC lifted its position in Intuitive Surgical by 85.4% during the fourth quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 41 shares during the last quarter. OFI Invest Asset Management acquired a new stake in Intuitive Surgical during the third quarter worth approximately $25,000. Finally, Headinvest LLC acquired a new stake in Intuitive Surgical during the third quarter worth approximately $28,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $368.93 on Tuesday. The firm’s fifty day moving average price is $386.57 and its two-hundred day moving average price is $344.41. The stock has a market cap of $130.77 billion, a PE ratio of 66.59, a PEG ratio of 5.69 and a beta of 1.36. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. The firm had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The company’s revenue was up 11.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.00 earnings per share. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a research report on Friday, January 19th. Royal Bank of Canada lifted their price target on shares of Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a research report on Wednesday, January 24th. Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research report on Friday. BTIG Research lifted their price target on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research report on Friday. Finally, Truist Financial lifted their price target on shares of Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Five analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $396.17.

Insiders Place Their Bets

In other Intuitive Surgical news, VP Fredrik Widman sold 5,041 shares of the business’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $397.07, for a total transaction of $2,001,629.87. Following the sale, the vice president now owns 110 shares of the company’s stock, valued at $43,677.70. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, VP Fredrik Widman sold 5,041 shares of Intuitive Surgical stock in a transaction on Friday, March 15th. The shares were sold at an average price of $397.07, for a total transaction of $2,001,629.87. Following the transaction, the vice president now owns 110 shares in the company, valued at $43,677.70. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Marshall Mohr sold 108,790 shares of Intuitive Surgical stock in a transaction on Wednesday, February 28th. The stock was sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the transaction, the vice president now owns 26,877 shares in the company, valued at approximately $10,349,795.16. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 248,418 shares of company stock valued at $95,927,097. 0.80% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.